IMMUNMODULATORISCHE PROTEINE

European patent · EP2908914 · In force

Register entry

Publication number
EP2908914
Application number
EP12788627
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 17, 2012
Published
Aug 26, 2015
Granted
Apr 18, 2018
Protection ends at the latest
Oct 16, 2032
Next annual fee due
Oct 31, 2026
IPC classes
A61K 38/00 (2006.01)
C07K 16/28 (2006.01)
C07K 14/47 (2006.01)
A61K 39/00 (2006.01)
C07K 16/00 (2006.01)
C07K 16/46 (2006.01)
PCT application
PCT/GB2012/052561 17.10.2012
PCT publication
WO2014/060712 24.04.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Sep 22, 2021

    Agent removed

    Representative
    TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly (removed)

    Published in Swissreg on 22.09.2021

  6. Oct 24, 2019

    Transferred

    Owner
    Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, United Kingdom → CSL Behring Lengnau AG, Industriestrasse 11, 2543 Lengnau BE

    Published in Swissreg on 24.10.2019

  7. Jul 5, 2018

    Agent entered

    Representative
    TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly

    Published in Swissreg on 05.07.2018

  8. Apr 18, 2018

    Granted

    Published in Swissreg on 18.04.2018

Parties

Holder

CSL Behring Lengnau AG

Industriestrasse 11, 2543 Lengnau BE

Inventor

PLEASS, Richard John

Liverpool L3 5QA, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.